Phase 3 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be younger than 75 years old.
- Your quality of life score, measured using a standard questionnaire called the EORTC QLQ-C30, must be at a level of 2 (confirm with trial site).
- You are expected to have a life expectancy of at least 10 years.
- You have been diagnosed with prostate cancer that has spread to a limited number of sites in the body (called oligometastatic prostate cancer), based on clinical and tissue assessments.
- Your doctors have determined that you are suitable to receive both radiotherapy (radiation treatment) and surgery to remove the prostate.
- You are willing to take part in the study and sign a consent form before joining.
Who may not be able to join:
- You have had a bone fracture caused by the cancer.
- You are unable to receive radiotherapy (radiation treatment) for any reason.
- The cancer has spread to internal organs such as the liver or lungs (known as visceral metastasis).
- You have a serious active infection.
- You have a history of blood clots in veins or arteries (thromboembolism).
- You have heart or cardiovascular problems that are not well managed or under control.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8613916989510
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to hormone-resistant prostate cancer (TTCRPC)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.